Hypoplastic Left Heart
6
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Treatment Research
4 treatments under study, led by Dexmedetomidine
Research Leaders
6 sponsors active, led by Athena Zuppa
Related Conditions
Often studied with 16 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
16.7%
1 terminated out of 6 trials
80.0%
-6.6% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Use of Oxandrolone to Promote Growth in Infants With HLHS
Cardiac Biomarkers in Patients With Single Ventricle Physiology
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery
NIRS in Neonatal Cardiac Surgery
Research Network
Common Treatments
- Dexmedetomidine2
- Oxandrolone1
- Nirs Evaluation1
- Norwood Palliation Dks Damuskayestansel Procedure1
Active Sponsors
- Athena Zuppa2
- Medtronic1
- Baylor College of Medicine1
- Emory University1
- McGill University Health Centre/Research Institute of the McGill University Health Centre1
Top Investigators
University of Mississippi Medical Center
McGill University Health Centre/Research Institute of the McGill University Health Centre
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Baylor College of Medicine
Related Conditions
- Tricuspid Atresia2
- Tetralogy Of Fallot2
- Congenital Heart Disease2
- Interrupted Aortic Arch1
- Heart Ventricle1